Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryoko Ogino
Observed name:
Ryoko OGINO
Institution:
Asubio Pharma Co., Ltd. (Japan)
Observed institutions:
Fukuoka University,
Suntory (Japan),
Asubio Pharma Co., Ltd. (Japan)
OpenAlex ID:
A5111551033
Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase
1991
·
Hidetsura Cho
, Masaru Ueda
, et al.
·
Journal of Medicinal Chemistry
·
113
New 5-HT1A receptor agonists possessing 1,4-Benzoxazepine scaffold exhibit highly potent anti-ischemic effects
2001
·
Katsuhide Kamei
, Noriko Maeda
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
57
Metabolite Profiles Correlate Closely with Neurobehavioral Function in Experimental Spinal Cord Injury in Rats
2012
·
Yusuke Fujieda
, Shinya Ueno
, et al.
·
PLoS ONE
·
24
Effect of bFGF on neuronal damage induced by sequential treatment of amyloid β and excitatory amino acid in vitro and in vivo
2012
·
Takafumi Noshita
, Norihito Murayama
, et al.
·
European Journal of Pharmacology
·
22
SUN11602, a Novel Aniline Compound, Mimics the Neuroprotective Mechanisms of Basic Fibroblast Growth Factor
2012
·
Norihito Murayama
, Taisuke Kadoshima
, et al.
·
ACS Chemical Neuroscience
·
18
SUN11602 has basic fibroblast growth factor-like activity and attenuates neuronal damage and cognitive deficits in a rat model of Alzheimer׳s disease induced by amyloid β and excitatory amino acids
2014
·
Ryoko Ogino
, Norihito Murayama
, et al.
·
Brain Research
·
14
PDF
SUN11602-induced hyperexpression of calbindin D-28k is pivotal for the survival of hippocampal neurons under neurotoxic conditions
2014
·
Norihito Murayama
, Takafumi Noshita
, et al.
·
Brain Research
·
13
Systemic treatment with a novel basic fibroblast growth factor mimic small-molecule compound boosts functional recovery after spinal cord injury
2020
·
Shiro Imagama
, Ryoko Ogino
, et al.
·
PLoS ONE
·
10
PDF
Studies of Cerebral Protective Agents. Preparation and Pharmacological Evaluation of 1-(1,4-Benzoquinon-2-yl)-1,2,3,4-tetrahydronaphthalenes as Potent Cerebral Protective Agents.
1996
·
Kenji SUZUKI
, Toshio TATSUOKA
, et al.
·
Chemical and Pharmaceutical Bulletin
·
8
PDF
2-Arylmethyl-1,4-benzoquinones. II. Novel Inhibitors of Platelet Aggregation: Synthesis and Pharmacological Evaluation.
1997
·
Kenji SUZUKI
, Toshio TATSUOKA
, et al.
·
Chemical and Pharmaceutical Bulletin
·
6
PDF
2-Arylmethyl-1,4-benzoquinones. I. Novel Inhibitors of Platelet Aggregation: Synthesis and Pharmacological Evaluation.
1996
·
Kenji SUZUKI
, Toshio TATSUOKA
, et al.
·
Chemical and Pharmaceutical Bulletin
·
4
PDF
Ghrelin attenuates disease progression in a mouse model of amyotrophic lateral sclerosis
2014
·
Tsuyoshi Matsuo
, Norihito Murayama
, et al.
·
F1000Research
·
3
ChemInform Abstract: New 5‐HT1A Receptor Agonists Possessing 1,4‐Benzoxazepine Scaffold Exhibit Highly Potent Anti‐Ischemic Effects.
2001
·
Katsuhide Kamei
, Noriko Maeda
, et al.
·
ChemInform
Effect of SUN N4057, a novel neuroprotectant, on cerebral infarction induced by thrombotic middle cerebral artery occlusion in rats.
1999
·
Makoto Koyama
, Teruyoshi Inoue
, et al.
·
The Japanese Journal of Pharmacology
SUN N4057, a novel neuroprotectant, strongly attenuates neuronal damage induced by transient focal cerebral ischemia in rats.
1999
·
Teruyoshi Inoue
, Ryoko Ogino
, et al.
·
The Japanese Journal of Pharmacology
Show more works
View as search
Works count:
15
Citation count:
292
H-index:
8
I10-index:
8
Year
Topic
Type
